Substituted triazoles as angiotensin II inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514340, 514383, 546276, 548252, 5482642, 5482644, A61K 3141, A61K 31435, C07D40312, C07D40314

Patent

active

052409538

ABSTRACT:
This invention relates to novel bis-biphenyl substituted 3-mercapto-1,2,4-tetrazoles and to pharmaceutically acceptable salts thereof.
The compounds are angiotensin II receptor antagonists, and are useful in treating hypertension (lowering high blood pressure), congestive heart failure, elevated ocular pressure, cerebral stroke, angina, cardiac insufficiency, myocardial infection or diabetic nephropathy.
The invention also relates to pharmaceutical composition comprising a compound of the invention, a method of treating a physiological condition in a mammal that is mediated by angiotensin II which comprises administering to the mammal an effective amount of a compound of the invention, and novel processes for preparing the compounds of the invention.

REFERENCES:
patent: 5093346 (1992-03-01), Carini et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted triazoles as angiotensin II inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted triazoles as angiotensin II inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted triazoles as angiotensin II inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2297627

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.